How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

The enemies are coming in waves, and your base isn’t going to defend itself… well, actually, it kind of is! Set up your defenses, watch them blast away at incoming threats. Redeem Idle Defense codes ...

It can be a little slow to find your footing in an AFK-style tower defense title, but with these Idle Defense codes, you'll get off to a flying start. Promising enough free upgrade materials to get ...

Rust enters the top 10 for the first time, Python keeps the lead, C moves back above C++, and SQL edges out R in July’s rankings update. Rust has entered the TIOBE Index top 10 for the first time in ...

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...